Navigation Links
Miscanthus has a fighting chance against weeds
Date:1/10/2011

University of Illinois research reports that several herbicides used on corn also have good selectivity to Miscanthus x giganteus (Giant Miscanthus), a potential bioenergy feedstock.

"No herbicides are currently labeled for use in Giant Miscanthus grown for biomass," said Eric Anderson, an instructor of bioenergy for the Center of Advanced BioEnergy Research at the University of Illinois. "Our research shows that several herbicides used on corn are also safe on this rhizomatous grass."

M. x giganteus is sterile and predominantly grown by vegetative propagation, or planting rhizomes instead of seed. This can be a very costly investment and requires a 1- to 2-year establishment period. Anderson's research showed that Giant Miscanthus does not compete well with weeds during establishment, especially early emerging weeds.

"There's a great cost in establishing Giant Miscanthus," Anderson said. "It's important to protect this investment, especially if it goes commercial. When weeds outcompete Giant Miscanthus, the result is stunted growth and lack of tillering. Basically, you are risking the crop's ability to overwinter."

The study, funded by the Ingersoll Fellowship, the Illinois Council on Food and Agricultural Research and the Energy Biosciences Institute, screened 16 post-herbicides and 6 pre-herbicides in a greenhouse setting. Several herbicides, particularly those with significant activity on grass species, caused plant injury ranging from 6 to 71 percent and/or reduced M. x giganteus dry mass by 33 to 78 percent.

Researchers then narrowed these herbicides down to the safest options and evaluated them in field trials replicated over two years. Field experiments confirmed the greenhouse experiments. Pre-emergence herbicides and herbicides with broadleaf-specific activity generally did not produce significant injury or reduce aboveground biomass while herbicides with considerable grass activity tended to cause injury ranging from 22 to 25 percent and reduce biomass by 69 to 78 percent.

"We discovered the anecdotes were true for the most part," he said. "Herbicides that are safe to use on corn demonstrate good selectivity to Giant Miscanthus."

Anderson said it's more difficult to kill a grass weed in a grass crop such as Giant Miscanthus. Identifying herbicides that don't hurt its yield or growth and maturity also posed challenges for researchers.

"I think the key is finding pre-emergence herbicides that you can get in early to take care of weed problems in Giant Miscanthus," he said.

Atrazine is one of the herbicides that proved safe on M. x giganteus.

"The good news is that atrazine is completely safe pre- or post-emergence," he said. "Atrazine is cheap and relatively effective. One of the major reasons we are continuing to screen more herbicides is to find additional effective options if atrazine utilization were limited in areas where Giant Miscanthus might be grown."

While there remains no approved label use for herbicides on M. x giganteus for biofuel production, Anderson hopes this research can serve as a foundation for either growers to begin an IR-4 specialty product process or for a major chemical company to add it to their label in the future.

Giant Miscanthus production is picking up in states such as Kentucky and Georgia, he said. He believes adding this feedstock to herbicide labels is not far off, but may be dependent on USDA's support of cellulosic ethanol.


'/>"/>

Contact: Jennifer Shike
jshike@illinois.edu
217-244-0888
University of Illinois College of Agricultural, Consumer and Environmental Sciences
Source:Eurekalert  

Related biology news :

1. New Miscanthus hybrid discovery in Japan could open doors for biofuel industry
2. Miscanthus, a biofuels crop, can host western corn rootworm
3. U of I scientists develop tool to trace metabolism of cancer-fighting tomato compounds
4. Discovery may help scientists boost broccoli’s cancer-fighting power
5. Fighting cancers by tagging their triggers
6. New infrared light may open new frontier in fighting cancer, Tay Sachs
7. U of Alberta researchers discover important mechanism in fighting infection
8. In the ring: Researchers fighting bacterial infections zero in on microorganisms soft spots
9. Symposium spotlights new paradigms in genomics, celebrates AIDS-fighting drug at 25 years
10. Fighting fungal infections with bacteria
11. UT Southwestern researchers identify key molecular step to fighting off viruses
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Miscanthus has a fighting chance against weeds
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
(Date:2/2/2017)...  EyeLock LLC, a market leader of iris-based identity ... What You Should Know About Biometrics in the Cloud ... is a growing concern. In traditional schemes, cryptography is ... authentication schemes such as username/password suffer from inherent weaknesses. ... an elegant solution to the problem of high-security user ...
(Date:1/30/2017)... FRANCISCO , Jan. 30, 2017   Invitae ... the fastest growing genetic information companies, today announced that ... financial results and provide 2017 guidance on Monday, February ... conference call that day at 4:45 p.m. Eastern / ... Invitae,s management team will briefly review financial results, guidance, ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... MILPITAS, Calif. , Feb. 17, 2017 /PRNewswire/ ... posters detailing data on its oral peptide drug ... Congress of the European Crohn,s and Colitis ... in Barcelona, Spain from ... The posters detail preclinical data on Protagonist drug ...
(Date:2/16/2017)... and GREENWICH, Conn. ... private investment firm focused on venture growth investments ... promotion of Josh Richardson , M.D. to ... investments in biotechnology companies.  He is a board ... important roles in Longitude,s investments in Aimmune Therapeutics, ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
(Date:2/16/2017)... , Feb. 16, 2017  Dermata Therapeutics, LLC, ... to treat a variety of dermatological diseases, today ... 1a financing and entered into a $5 million ... intends to use the capital for general corporate ... advancements in the treatment of serious diseases treated ...
Breaking Biology Technology: